Cargando…

Association between induction of the self-management system for preventing readmission and disease severity and length of readmission in patients with heart failure

OBJECTIVE: We recently developed the self-management system using the HF points and instructions to visit hospitals or clinics when the points exceed the pre-specified levels. We found that the self-management system decreased the hospitalization for HF with an increase in unplanned visits and early...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakane, Eisaku, Kato, Takao, Tanaka, Nozomi, Kuriyama, Tomoari, Kimura, Koki, Nishiwaki, Shushi, Hamaguchi, Toka, Morita, Yusuke, Yamaji, Yuhei, Haruna, Yoshisumi, Haruna, Tetsuya, Inoko, Moriaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684164/
https://www.ncbi.nlm.nih.gov/pubmed/34922617
http://dx.doi.org/10.1186/s13104-021-05864-6
Descripción
Sumario:OBJECTIVE: We recently developed the self-management system using the HF points and instructions to visit hospitals or clinics when the points exceed the pre-specified levels. We found that the self-management system decreased the hospitalization for HF with an increase in unplanned visits and early intervention in the outpatient department. However, it is unclear whether we managed severe HF outpatients who should have been hospitalized. In this study, we aimed to compare HF severity in rehospitalized patients with regard to self-management system use. RESULTS: We retrospectively enrolled 306 patients (153 patients each in the system user and non-user groups) using propensity scores (PS). We compared HF severity and length of readmission in rehospitalized patients in both groups. During the 1-year follow-up period, 24 system users and 43 non-system users in the PS-matched cohort were hospitalized. There were no significant differences between the groups in terms of brain natriuretic peptide levels at readmission, maximum daily intravenous furosemide dose, percentage of patients requiring intravenous inotropes, duration of hospital stay and in-hospital mortality. These results suggest that the HF severity in rehospitalized patients was not different between the two groups. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-021-05864-6.